Targeting α-Synuclein as a therapy for Parkinson's disease: The battle begins. [electronic resource]
- Movement disorders : official journal of the Movement Disorder Society 02 2017
- 203-207 p. digital
Publication Type: Journal Article; Comment
1531-8257
10.1002/mds.26935 doi
Humans Neurons Parkinson Disease Substantia Nigra alpha-Synuclein